La Clinica terapeutica
-
La Clinica terapeutica · Jan 1998
Clinical Trial Controlled Clinical TrialPlatinum compounds as radiosensitizers in strontium-89 metabolic radiotherapy.
Strontium-89 is currently used for the treatment of painful bone metastases. This study reports on two preliminary experiences with low-dose platinum compounds, carboplatin and cisplatin, as radiosensitizers in 89Sr therapy. ⋯ Low-dose platinum compounds seem to enhance the effects of 89Sr radioisotope therapy on pain from bone metastases without relevant hematological toxicity.